Takeda Pharmaceutical TAK
NYSE TAK
$20.25 -0.12 (-0.59%)
At close: Oct 23, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Gains from Equity Investments (2018 - 2019)

Updated

Takeda Pharmaceutical (TAK) recorded Gains from Equity Investments of $2.33 billion in the year ended Dec 31, 2018, down 45.5% from $4.27 billion a year earlier.

Analysis

Takeda Pharmaceutical (TAK) Gains from Equity Investments (2018 - 2019) Analysis & Trends

  • Per Business Quant data, TAK's Gains from Equity Investments was $4.27 billion in the year ended Dec 31, 2017 and $327.4 million in the year ended Dec 31, 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Takeda Pharmaceutical 64.44 Bn 40.82 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -15.72 Mn
Jun 30, 2019 -21.32 Mn
Mar 31, 2019 -795.58 Mn
Dec 31, 2018 425.49 Mn
Sep 30, 2018 -4.23 Mn
Jun 30, 2018 -32.65 Mn
Mar 31, 2018 -604.65 Mn
API Access

Takeda Pharmaceutical Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=TAK&period=max&api_key=YOUR_API_KEY